Colon and Rectal Cancer

• Participant Clinical Case Discussion: Major Response to Anti-EGFR Reintroduction in Liver Limited RAS wt mCRC, Relapsed After Initial Panitumumab/C...
• Participant Clinical Case Discussion: Multidisciplinary Approach for Long Survivals
• Management of Treatment Related Side Effects
• Immunotherapy in Gastrointestinal Cancers
• Standard of Care for Anal Canal Squamous Carcinomas
• Participant Clinical Case Discussion: Case Presentation, Metastatic Colon cancer
• Participant Clinical Case Discussion: 2nd Line Treatment in Metastatic Rectal Cancer
• The Role of Maintenance, Appropriate Endpoints According to ESMO Consensus
• What to do After first-line Failure
• How to Deal with Patients with Isolated Peritoneal Metastases
• Participant Clinical Case Discussion: A 42 Year Old Man With KRAS Wild Type Rectal Cancer
• Participant Clinical Case Discussion: A Decade of Treatment of the Primary Metastatic Colorectal Cancer
• Participant Clinical Case Discussion: Complete Remission of Metastatic Rectal Cancer After Panitumumab Containing Chemotherapy
• Oligometastatic colorectal cancer: What to know about and how to treat it
• Presentation of Three Challenging Clinical Cases and Faculty discussion
• How to Integrate Surgery in The treatment of Patients with Liver-only Metastatic Disease
• How to Deal With Elderly Patients or Individuals with Comorbidities
• How to Deal with Synchronous Primary and Liver Metastases
• Adjuvant Treatment for Elderly Patients: How to Address it
• Participant Clinical Case Discussion: MRI in Rectal Cancer Treatment Response Evaluation, Impact on Treatment Decision (Case Series)
• Review of the ESMO Consensus Conference on Metastatic Colorectal Cancer
• Chemotherapy and Targeted Agents in first-line
• RAS, BRAF: Microsatellite Instability and Other Molecular Markers – How Useful are They? Pitfalls in Diagnostic?
• Adjuvant Treatment for Colon Cancer II and III

• « Previous
• 1
• 2
• ...
• 65
• Next »